Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 76.78%7.48B | 3.07%4.23B | -14.82%4.1B | -35.62%4.82B | 2.03%7.48B | 26.14%7.34B | 16.37%5.82B | 20.53%5B | -4.23%4.15B | 87.97%4.33B |
Net profit before non-cash adjustment | -4.98%6.85B | 18.48%7.21B | 46.34%6.08B | -20.34%4.16B | -20.94%5.22B | 5.52%6.6B | 19.28%6.25B | -3.02%5.24B | 1.62%5.41B | 19.02%5.32B |
Total adjustment of non-cash items | -50.79%561M | -21.43%1.14B | 44.09%1.45B | -14.37%1.01B | 4.16%1.18B | 67.26%1.13B | 15.38%675M | -12.29%585M | 138.21%667M | -23.91%280M |
-Depreciation and amortization | -20.82%1.27B | 3.42%1.6B | 34.87%1.55B | -0.69%1.15B | 11.03%1.16B | 38.33%1.04B | 18.00%754M | 13.10%639M | 38.14%565M | -0.73%409M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.78%210M | --216M |
-Disposal profit | -2.23%-459M | ---449M | --0 | -88.41%19M | -6.29%164M | --175M | ---- | ---- | 79.66%-60M | -1,080.00%-295M |
-Other non-cash items | -1,566.67%-250M | 85.00%-15M | 38.27%-100M | -10.96%-162M | -64.04%-146M | -12.66%-89M | -46.30%-79M | -12.50%-54M | 4.00%-48M | -163.16%-50M |
Changes in working capital | 101.70%70M | -19.96%-4.12B | -900.58%-3.43B | -131.47%-343M | 378.77%1.09B | 65.00%-391M | -34.09%-1.12B | 56.79%-833M | -51.69%-1.93B | 49.88%-1.27B |
-Change in receivables | -324.51%-1.96B | 90.82%-461M | -724.30%-5.02B | -119.33%-609M | 364.75%3.15B | 110.75%678M | -27.39%-6.31B | -953.40%-4.95B | 81.92%-470M | 28.14%-2.6B |
-Change in inventory | 104.52%158M | 15.76%-3.5B | -643.91%-4.15B | 221.94%763M | 112.24%237M | -17.68%-1.94B | -120.64%-1.65B | -42.10%-746M | -135.43%-525M | 74.80%-223M |
-Change in payables | 922.49%2.14B | -94.94%209M | 681.43%4.13B | 65.87%-711M | -301.65%-2.08B | -83.42%1.03B | 33.94%6.23B | 884.49%4.65B | -132.58%-593M | 0.33%1.82B |
-Provision for loans, leases and other losses | -78.26%15M | -29.59%69M | 228.95%98M | 30.91%-76M | -71.88%-110M | -172.73%-64M | 700.00%88M | 102.78%11M | -38.95%-396M | -870.27%-285M |
-Changes in other current assets | -327.96%-636M | -66.14%279M | 292.07%824M | -627.12%-429M | -140.97%-59M | 1,540.00%144M | -176.92%-10M | 117.81%13M | -630.00%-73M | 28.57%-10M |
-Changes in other current liabilities | 149.23%353M | -205.13%-717M | -5.15%682M | 1,663.04%719M | 81.22%-46M | -146.49%-245M | 180.32%527M | 45.74%188M | 377.78%129M | -79.23%27M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 6.55%-157M | 5.62%-168M | -249.02%-178M | 3.77%-51M | 11.67%-53M | 11.76%-60M | -9.68%-68M | 7.46%-62M | 4.29%-67M | 4.11%-70M |
Interest received (cash flow from operating activities) | 7.36%350M | 27.84%326M | 14.86%255M | 15.03%222M | 11.56%193M | 13.82%173M | 27.73%152M | 0.85%119M | 0.85%118M | 23.16%117M |
Tax refund paid | -11.62%-2.54B | -104.23%-2.27B | 19.60%-1.11B | 32.44%-1.38B | 7.33%-2.05B | -18.19%-2.21B | -16.67%-1.87B | 17.17%-1.6B | 5.10%-1.93B | -47.36%-2.04B |
Other operating cash inflow (outflow) | -11,200.00%-113M | 0.00%-1M | -200.00%-1M | 200.00%1M | -1M | 0 | 0.00%-1M | -1M | 0 | 200.00%1M |
Operating cash flow | 137.38%5.02B | -31.03%2.12B | -14.94%3.07B | -35.31%3.61B | 6.43%5.58B | 30.03%5.24B | 16.75%4.03B | 52.50%3.45B | -3.25%2.26B | 148.57%2.34B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -7.62%-1.61B | 51.40%-1.5B | -252.17%-3.08B | -28.34%-874M | -191.03%-681M | 16.43%-234M | -305.80%-280M | 94.84%-69M | 2.41%-1.34B | -188.42%-1.37B |
Net intangibles purchase and sale | -406.25%-324M | 75.19%-64M | -50.00%-258M | -391.43%-172M | 82.93%-35M | 89.42%-205M | -308.86%-1.94B | ---474M | ---- | ---- |
Net business purchase and sale | ---1.9B | --0 | ---- | --5M | ---- | -361.73%-374M | ---81M | ---- | ---- | ---94M |
Net investment product transactions | -18.07%1.38B | 475.95%1.69B | 91.87%-449M | 2.51%-5.52B | -147.01%-5.66B | -138.70%-2.29B | 161.30%5.93B | -4,781.31%-9.67B | -141.42%-198M | -43.96%478M |
Advance cash and loans provided to other parties | --0 | -800.00%-9M | 0.00%-1M | 99.10%-1M | -1,010.00%-111M | 85.92%-10M | -7,000.00%-71M | ---1M | --0 | 54.69%-29M |
Repayment of advance payments to other parties and cash income from loans | -16.67%5M | -14.29%6M | -94.12%7M | 495.00%119M | -66.67%20M | 566.67%60M | -55.00%9M | -9.09%20M | -73.17%22M | 290.48%82M |
Net changes in other investments | 116.46%13M | -977.78%-79M | 106.87%9M | -404.65%-131M | 138.89%43M | 80.00%18M | 233.33%10M | 101.03%3M | -249.40%-290M | -62.75%-83M |
Investing cash flow | -5,386.96%-2.43B | 101.22%46M | 42.67%-3.77B | -2.30%-6.58B | -111.59%-6.43B | -185.00%-3.04B | 135.09%3.57B | -464.95%-10.19B | -77.46%-1.8B | -457.75%-1.02B |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | 42.86%-4M | 58.82%-7M | ---17M | ---- |
Net common stock issuance | ---2.5B | --0 | --0 | ---219M | ---- | ---- | --0 | --0 | ---110M | --0 |
Increase or decrease of lease financing | 23.23%-347M | 1.74%-452M | -70.37%-460M | -12.97%-270M | 7.36%-239M | 1.90%-258M | -90.58%-263M | 0.72%-138M | -9.45%-139M | -7.63%-127M |
Cash dividends paid | -0.10%-2.04B | -62.47%-2.04B | 11.12%-1.26B | 0.07%-1.41B | -12.50%-1.41B | -14.39%-1.26B | -7.44%-1.1B | -18.01%-1.02B | -23.01%-866M | -11.92%-704M |
Net other fund-raising expenses | ---- | ---- | ---- | 99.10%-1M | ---111M | ---- | -100.00%-2M | ---1M | ---- | 0.00%-1M |
Financing cash flow | -96.31%-4.89B | -45.25%-2.49B | 9.83%-1.72B | -7.88%-1.9B | -16.45%-1.76B | -10.75%-1.51B | -17.04%-1.37B | -3.18%-1.17B | -36.06%-1.13B | -11.23%-832M |
Net cash flow | ||||||||||
Beginning cash position | -1.81%15.37B | -12.88%15.65B | -21.25%17.97B | -10.29%22.81B | 2.74%25.43B | 33.71%24.75B | -30.01%18.51B | -2.56%26.45B | 4.57%27.14B | 1.88%25.96B |
Current changes in cash | -598.78%-2.3B | 86.39%-329M | 50.38%-2.42B | -86.27%-4.87B | -480.64%-2.62B | -88.98%687M | 178.91%6.24B | -1,076.04%-7.9B | -236.86%-672M | 2.94%491M |
Effect of exchange rate changes | 202.22%136M | -55.88%45M | 325.00%102M | --24M | --0 | -500.00%-8M | 105.88%2M | -78.95%-34M | ---19M | --0 |
Cash adjustments other than cash changes | --352M | ---- | ---- | ---- | 0.00%-1M | -150.00%-1M | 300.00%2M | 66.67%-1M | -200.00%-3M | -200.00%-1M |
End cash Position | -11.78%13.56B | -1.81%15.37B | -12.88%15.65B | -21.25%17.97B | -10.29%22.81B | 2.74%25.43B | 33.71%24.75B | -30.01%18.51B | 0.01%26.45B | 1.89%26.45B |
Free cash flow | 446.40%3.04B | 307.46%556M | -110.46%-268M | -47.29%2.56B | 1.23%4.86B | 165.05%4.8B | -37.72%1.81B | 411.97%2.91B | 27.35%568M | -4.29%446M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |